Shizain Drugs And Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 11-12-2024
- Paid Up Capital ₹ 0.30 M
as on 11-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.03 Cr
as on 11-12-2024
- Revenue -90.26%
(FY 2022)
- Profit -144.89%
(FY 2022)
- Ebitda -91.45%
(FY 2022)
- Net Worth -12.78%
(FY 2022)
- Total Assets -28.60%
(FY 2022)
About Shizain Drugs And Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.03 Cr.
Aniruddha Hati and Sankar Sarkar serve as directors at the Company.
- CIN/LLPIN
U74999WB2017PTC219448
- Company No.
219448
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shizain Drugs And Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniruddha Hati  | Director | 14-Feb-2017 | Current |
| Sankar Sarkar | Director | 14-Feb-2017 | Current |
Financial Performance of Shizain Drugs And Pharmaceutical.
Shizain Drugs And Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 90.26% decrease. The company also saw a substantial fall in profitability, with a 144.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shizain Drugs And Pharmaceutical?
In 2020, Shizain Drugs And Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wishful Fisheries Private LimitedActive 2 years 9 monthsAniruddha Hati and Sankar Sarkar are mutual person
- Elderprime India Pharmaceuticals Private LimitedActive 2 years 9 months
Sankar Sarkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 May 2018 | ₹0.29 M | Open |
Others Creation Date: 14 Jun 2017 | ₹1.00 Cr | Open |
How Many Employees Work at Shizain Drugs And Pharmaceutical?
Unlock and access historical data on people associated with Shizain Drugs And Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shizain Drugs And Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shizain Drugs And Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
